Time-dependent changes in striatal xCT protein expression in hemi-Parkinson rats
- 29 October 2008
- journal article
- research article
- Published by Wolters Kluwer Health in NeuroReport
- Vol. 19 (16) , 1589-1592
Abstract
Altered glutamate signaling is associated with Parkinson's disease. To study the involvement of the cystine/glutamate antiporter in the pathogenesis of Parkinson's disease, we developed new polyclonal antibodies recognizing xCT, the specific subunit of this antiporter. The striatal xCT protein expression level was investigated in a hemi-Parkinson rat model, using semiquantitative western blotting. We observed time-dependent changes after a unilateral 6-hydroxydopamine lesion of the nigrostriatal pathway with increased expression levels in the deafferented striatum after 3 weeks. Twelve weeks postlesion, expression levels returned to normal. These data suggest, for the first time, an involvement of the cystine/glutamate antiporter in determining the aberrant glutamate neurotransmission in the striatum of a parkinsonian brain.Keywords
This publication has 23 references indexed in Scilit:
- Microglia and inflammation-mediated neurodegeneration: Multiple triggers with a common mechanismProgress in Neurobiology, 2005
- The effect of 6‐hydroxydopamine lesions on the release of amino acids in the direct and indirect pathways of the basal ganglia: a dual microdialysis probe analysisEuropean Journal of Neuroscience, 2003
- Adenosine A2A receptor antagonism increases striatal glutamate outflow in dopamine-denervated ratsEuropean Journal of Pharmacology, 2003
- Oxidative Glutamate Toxicity Can Be a Component of the Excitotoxicity CascadeJournal of Neuroscience, 2001
- Functional changes of the basal ganglia circuitry in Parkinson's diseaseProgress in Neurobiology, 2000
- Cloning and Expression of a Plasma Membrane Cystine/Glutamate Exchange Transporter Composed of Two Distinct ProteinsJournal of Biological Chemistry, 1999
- Synaptic Plasticity in the Caudate Nucleus of Patients with Parkinson's DiseaseNeurodegeneration, 1996
- Alterations in glutathione levels in Parkinson's disease and other neurodegenerative disorders affecting basal gangliaAnnals of Neurology, 1994
- Morphological changes in the rat neostriatum after unilateral 6-hydroxydopamine injections into the nigrostriatal pathwayExperimental Brain Research, 1993
- Idiopathic Parkinson's disease, progressive supranuclear palsy and glutathione metabolism in the substantia nigra of patientsNeuroscience Letters, 1986